iifl-logo

Kabra Drugs Ltd Share Price Live

Add as a Preferred Source on Google
₹24.98
(0.77%)
May 15, 2026|05:30:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Equities

Futures

Option

  • Open₹25.29
  • Day's High₹25.99
  • 52 Wk High₹35.52
  • Prev. Close₹24.79
  • Day's Low₹24.06
  • 52 Wk Low ₹11.63
  • Turnover (lac)8.97
  • P/E13.7
  • Face Value₹10
  • Book Value₹10.96
  • EPS1.81
  • Mkt. Cap (Cr.)₹59.22
  • Div. Yield0
View All Historical Data

No Record Found

No Record Found

Kabra Drugs Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

₹25.29

Prev. Close

₹24.79

Turnover(Lac.)

₹8.97

Day's High

₹25.99

Day's Low

₹24.06

52 Week's High

₹35.52

52 Week's Low

₹11.63

Book Value

₹10.96

Face Value

₹10

Mkt Cap (₹ Cr.)

59.22

P/E

13.7

EPS

1.81

Divi. Yield

0

Kabra Drugs Ltd Corporate Action

2 Sep 2025

12:00 AM

AGM

Announcement Date: 02 Sep, 2025

arrow

2 Sep 2025

12:00 AM

BookCloser

arrow

27 Apr 2026

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

28 Nov 2025

12:00 AM

EGM

arrow

Kabra Drugs Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Knowledge Center

Demat Account

View More

Trading Account

View More

Kabra Drugs Ltd SHAREHOLDING SNAPSHOT

16 May, 2026|11:04 PM
Mar-2026Dec-2025Sep-2025Jun-2025
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 0.00%

Foreign: 0.00%

Indian: 0.00%

Non-Promoter- 1000.00%

Institutions: 0.00%

Non-Institutions: 100.00%

Custodian: 0.00%

Read More
Share PriceShare Price

Kabra Drugs Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2025Mar-2024Mar-2023Mar-2022

Equity Capital

23.71

6.94

4.39

4.39

Preference Capital

0

0

0

0

Reserves

0.95

-5.86

-5.12

-4.78

Net Worth

24.66

1.08

-0.73

-0.39

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2019Mar-2018

Revenue

0

0

0

1.8

yoy growth (%)

0

0

-100

-76.3

Raw materials

0

0

0

-1.27

As % of sales

0

0

0

70.86

Employee costs

-0.04

0

-0.03

-1.17

View Profit & Loss
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2019Mar-2018

Profit before tax

-0.18

-0.05

-0.16

-1.41

Depreciation

-0.03

-0.03

-0.03

-0.13

Tax paid

0

0

0

0

Working capital

0.1

0

-0.12

-0.9

Other operating items

View Cash Flow
Y/e 31 MarMar-2021Mar-2020Mar-2019Mar-2018

Growth matrix (%)

Revenue growth

0

0

-100

-76.3

Op profit growth

198.36

-63.66

-86.72

-334.74

EBIT growth

207.45

-63.16

-86.27

-477.56

Net profit growth

202.1

-63.82

-93

-1,909.97

View Ratios

No Record Found

Kabra Drugs Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceutical Industries Ltd

SUNPHARMA

1,880

102.434,47,032.09705.440.865,651.2199.24

Divis Laboratories Ltd

DIVISLAB

6,761.1

71.431,83,758.685980.432,578578.26

Torrent Pharmaceuticals Ltd

TORNTPHARM

4,406.15

66.811,49,223.985770.142,547249.82

Cipla Ltd

CIPLA

1,431.55

31.41,16,211.65384.640.93,840.92423.39

Dr Reddys Laboratories Ltd

DRREDDY

1,336.95

33.771,08,739.11-219.40.613,802.6375.78

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

View All Peer Comparision

MORE ABOUT Kabra Drugs Ltd

Management

Register Office

Registrar Office

Executive Director & MD

N Aravind

Executive Director / Whole Time Director / CFO

Venkatakrishnappa Ananth Kumar

Executive Director

KUNIAMUTHUR NANJAPPAN ANAND

Independent Director

Ananthkumar Shilpa

Independent Director

A Anitha

Company Sec. & Compli. Officer

Monika Sanwal

Registered Office

270 Shastri Market Indore,

Madhya Pradesh - 452007

Tel: -

Website: http://www.kabradrugs.com

Email: kabradrugs@gmail.com

Registrar Office

Plot No. 60,

Electronic Complex, Pardeshipura,

Indore - 452010

Tel: 91-0731-3198601/3198

Website: www.ankitonline.org

Email: ankit_4321@yahoo.com

Summary

Kabra Drugs Limited was incorporated as a Limited Company on August 22, 1989. The Company has set up a Unit at Indore for manufacturing of Ether derivatives which includes Diethyl Ether (Anesthesia), ...
Read More

Reports by Kabra Drugs Ltd

Company FAQs

What is the Kabra Drugs Ltd share price today?

The Kabra Drugs Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹24.98 today.

What is the Market Cap of Kabra Drugs Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Kabra Drugs Ltd is ₹59.22 Cr. as of 15 May ‘26

What is the PE and PB ratio of Kabra Drugs Ltd?

The PE and PB ratios of Kabra Drugs Ltd is 13.7 and 2.26 as of 15 May ‘26

What is the 52 Week High and Low of Kabra Drugs Ltd?

The 52-week high/low is the highest and lowest price at which a Kabra Drugs Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Kabra Drugs Ltd is ₹11.63 and ₹35.52 as of 15 May ‘26

What is the CAGR of Kabra Drugs Ltd?

Kabra Drugs Ltd's CAGR for 5 Years at 45.28%, 3 Years at 66.20%, 1 Year at 113.16%, 6 Month at 8.73%, 3 Month at -28.50% and 1 Month at -12.15%.

What is the shareholding pattern of Kabra Drugs Ltd?

The shareholding pattern of Kabra Drugs Ltd is as follows:
Promoters - 0.00 %
Institutions - 0.00 %
Public - 100.00 %

QUICKLINKS FOR Kabra Drugs Ltd

Information
Share PriceFutures PriceOption ChainHistorical Data
Financials
Profit & LossBalance SheetCash FlowKey Ratios
Results
Quarterly ResultHalf Yearly ResultNine Monthly ResultAnnual Result
News
Company
Market
Derivatives
IPO
Mutual Funds
Calculators
Nifty 50
Company
Knowledge Center
News
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

About
IIFL Group
Products & Services
Trading Documentation
Useful Links
For Investors

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.